This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07853/identifier/chemspider/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB07853/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07853/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07853/identifier/pubchem-substance/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07853/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07853
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07853 n8:DB07853
dcterms:title
[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE
adms:identifier
n10:99444324 n11:GVD n12:46937100 n13:22377303 n14:DB07853
n3:IUPAC-Name
n4:271B459E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B45A4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B45A3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B45A0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B45A1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B45A2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B459C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B459A-363D-11E5-9242-09173F13E4C5 n4:271B459D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B459B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B45AA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B45AB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B45A5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B45A6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B45A8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B45A7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B45A9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B45B0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B45B2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B45B3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B45AF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B45AE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B45B1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B459F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B45AC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B45AD-363D-11E5-9242-09173F13E4C5